Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CKD With Hepatitis C”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableWithdrawnNCT02563665
What this trial is testing

Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy

Who this might be right for
CKD With Hepatitis C
Institute of Liver and Biliary Sciences, India
Large-scale testing (Phase 3)Study completedNCT03069365
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 101
Post-approval studies (Phase 4)Study completedNCT03063879
What this trial is testing

Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir

Who this might be right for
Hepatitis C, ChronicChronic Renal Failure
Tehran University of Medical Sciences 95
Post-approval studies (Phase 4)Study completedNCT02946034
What this trial is testing

Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C

Who this might be right for
Chronic Kidney DiseaseChronic Hepatitis C
Massachusetts General Hospital 10
Not applicableUnknownNCT06104046
What this trial is testing

Prevalence of Seroconversion of Hepatitis c Virus Among Children With CKD on Regular Hemodialysis

Who this might be right for
Hepatitis C Virus
Assiut University 50
Post-approval studies (Phase 4)Study completedNCT00474955
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 27
Post-approval studies (Phase 4)Study completedNCT02902120
What this trial is testing

HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant

Who this might be right for
Hepatitis CRenal Insufficiency, ChronicDisorder of Transplanted Kidney
University of Maryland, Baltimore 21
Not applicableStudy completedNCT03426787
What this trial is testing

Helping Empower Liver and Kidney Patients

Who this might be right for
Hepatitis CChronic Kidney DiseasesPatient Education
Washington University School of Medicine 70
Large-scale testing (Phase 3)Study completedNCT02487199
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 18
Not applicableStudy completedNCT03145623
What this trial is testing

Retrospective Efficacy and Safety Study With Elbasvir/Grazoprevir in HCV-infected Patients With Chronic Kidney Disease

Who this might be right for
Hepatitis CChronic Kidney Diseases
University Hospital, Toulouse 100
Not applicableEnded earlyNCT02503735
What this trial is testing

Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)

Who this might be right for
Hepatitis CChronic Kidney Disease
Massachusetts General Hospital 14
Large-scale testing (Phase 3)Study completedNCT02092350
What this trial is testing

Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052)

Who this might be right for
Hepatitis C Virus
Merck Sharp & Dohme LLC 237
Post-approval studies (Phase 4)Study completedNCT03144635
What this trial is testing

G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir

Who this might be right for
Hepatitis C ViralChronic Kidney Disease stage3
Kyushu University 80
Large-scale testing (Phase 3)Study completedNCT02207088
What this trial is testing

Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease

Who this might be right for
Chronic Hepatitis CHepatitis C VirusCompensated Cirrhosis+2 more
AbbVie 68
Post-approval studies (Phase 4)Study completedNCT02580474
What this trial is testing

The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure

Who this might be right for
Hepatitis C
Myeong Jun Song 21